SDC1 and cancer: The in vitro silencing of syndecan-1 strongly destabilizes the holoclones by increasing ROS production, whereas in vivo syndecan-1 deficiency lowers the frequency of primitive cells expressing stem cell markers and markedly represses cancer propagation.